Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$5.77 - $7.96 $161,133 - $222,290
-27,926 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$6.67 - $9.8 $186,266 - $273,674
27,926 New
27,926 $222,000
Q1 2019

Apr 29, 2019

SELL
$1.5 - $2.34 $3,486 - $5,438
-2,324 Closed
0 $0
Q4 2018

Jan 28, 2019

BUY
$1.88 - $5.25 $4,369 - $12,201
2,324 New
2,324 $4,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $73.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.